Smruthi Organics Limited (BOM:540686)

India · Delayed Price · Currency is INR

121.60

-0.65 (-0.53%)

At close: Aug 21, 2026

2.88% (1Y)

Market Cap	1.39B +2.9%
Revenue (ttm)	1.12B -4.5%
Net Income	73.99M +118.2%
EPS	6.45 +118.1%
Shares Out	11.45M
PE Ratio	18.81
Forward PE	n/a
Dividend	1.50 (1.19%)
Ex-Dividend Date	Jul 31, 2026

Volume	3,615
Open	123.00
Previous Close	122.25
Day's Range	121.15 - 123.00
52-Week Range	95.00 - 164.00
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Smruthi Organics

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company operates through Bulk Drugs and Drugs Intermediates (API), and Formulation segments. The company provides API for cardiovascular, such as amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of diloxanide furoate, norfloxacin, a... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1989

Employees 261

Stock Exchange Bombay Stock Exchange

Ticker Symbol 540686

Full Company Profile

Financial Performance

In fiscal year 2026, Smruthi Organics's revenue was 1.02 billion, a decrease of -19.08% compared to the previous year's 1.26 billion. Earnings were 34.26 million, a decrease of -3.85%.

Financial Statements